{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:14:06Z","timestamp":1778692446926,"version":"3.51.4"},"reference-count":48,"publisher":"BMJ","issue":"13","funder":[{"name":"Biomedical Research Centre"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/17\/3\/32774"],"award-info":[{"award-number":["RG\/17\/3\/32774"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S037306\/1"],"award-info":[{"award-number":["MR\/S037306\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2021,9,23]]},"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Dilated cardiomyopathy (DCM) is a common yet challenging cardiac disease. Great strides have been made in improving DCM prognosis due to heart failure but sudden cardiac death (SCD) due to ventricular arrhythmias remains significant and challenging to predict. High-risk patients can be effectively managed with implantable cardioverter defibrillators (ICDs) but because identification of what is high risk is very limited, many patients unnecessarily experience the morbidity associated with an ICD implant and many others are not identified and have preventable mortality. Current guidelines recommend use of left ventricular ejection fraction and New York Heart Association class as the main markers of risk stratification to identify patients who would be at higher risk of SCD. However, when analysing the data from the trials that these recommendations are based on, the number of patients in whom an ICD delivers appropriate therapy is modest. In order to improve the effectiveness of therapy with an ICD, the patients who are most likely to benefit need to be identified. This review article presents the evidence behind current guideline-directed SCD risk markers and then explores new potential imaging, electrophysiological and genetic risk markers for SCD in DCM.<\/jats:p>","DOI":"10.1136\/heartjnl-2021-319971","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T14:40:36Z","timestamp":1634740836000},"page":"998-1004","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Non-invasive markers for sudden cardiac death risk stratification in dilated cardiomyopathy"],"prefix":"10.1136","volume":"108","author":[{"given":"Vivetha","family":"Pooranachandran","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"NIHR Leicester Biomedical Research Centre, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Nicolson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"Department of Cardiology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakariyya","family":"Vali","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"Department of Cardiology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"School of Engineering, University of Leicester College of Science and Engineering, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-0671","authenticated-orcid":false,"given":"G Andre","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"NIHR Leicester Biomedical Research Centre, Leicester, UK"},{"name":"Department of Cardiology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"2025100702185661000_108.13.998.1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0495-4"},{"key":"2025100702185661000_108.13.998.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.054"},{"key":"2025100702185661000_108.13.998.3","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.115"},{"key":"2025100702185661000_108.13.998.4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ejhf.1548","article-title":"The dapagliflozin and prevention of adverse-outcomes in heart failure (DAPA-HF) trial: baseline characteristics","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025100702185661000_108.13.998.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033088"},{"key":"2025100702185661000_108.13.998.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608029"},{"key":"2025100702185661000_108.13.998.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.478"},{"key":"2025100702185661000_108.13.998.8","unstructured":"National Institute of Health and Care Excellence . NICE technology appraisal [TA 314]: Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120), 2014."},{"key":"2025100702185661000_108.13.998.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399"},{"key":"2025100702185661000_108.13.998.10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2017.04.020","article-title":"Meta-analysis of risk of ventricular arrhythmias after improvement in left ventricular ejection fraction during follow-up in patients with primary prevention implantable cardioverter defibrillators","volume":"120","author":"Smer","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025100702185661000_108.13.998.11","doi-asserted-by":"crossref","unstructured":"Mercier T , Hebbar E , Fertin M , et al . P2276 Sudden cardiac death in non-ischemic systolic heart failure: do we only need LVEF to decide ICD implantation? Eur Heart J 2019;40.doi:10.1093\/eurheartj\/ehz748.0753","DOI":"10.1093\/eurheartj\/ehz748.0753"},{"key":"2025100702185661000_108.13.998.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.045"},{"key":"2025100702185661000_108.13.998.13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ehf2.12548","article-title":"Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy","volume":"7","author":"Briongos-Figuero","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025100702185661000_108.13.998.14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in-congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"The Lancet"},{"key":"2025100702185661000_108.13.998.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.12.021"},{"key":"2025100702185661000_108.13.998.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2008.00988.x"},{"key":"2025100702185661000_108.13.998.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1363"},{"key":"2025100702185661000_108.13.998.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2016.09.017"},{"key":"2025100702185661000_108.13.998.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-17-S1-P191","article-title":"Cardiovascular magnetic resonance guided management of mild-moderate left ventricular systolic heart failure (CMR guide HF): study protocol for a randomised controlled trial","volume":"17","author":"Selvanayagam","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025100702185661000_108.13.998.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9314-2"},{"key":"2025100702185661000_108.13.998.21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jelectrocard.2016.03.012","article-title":"Sudden cardiac death markers in non-ischemic cardiomyopathy","volume":"49","author":"Pimentel","year":"2016","journal-title":"J Electrocardiol"},{"key":"2025100702185661000_108.13.998.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2011.04.033"},{"key":"2025100702185661000_108.13.998.23","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ehf2.12689","article-title":"Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta-analysis and systematic review","volume":"7","author":"Sammani","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025100702185661000_108.13.998.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(02)00207-3"},{"key":"2025100702185661000_108.13.998.25","doi-asserted-by":"crossref","first-page":"182618680700300","DOI":"10.1177\/1826186807003001-207","article-title":"Heart rate turbulence and variability in patients with ventricular arrhythmias","volume":"3","author":"Lombardi","year":"2007","journal-title":"Heart Int"},{"key":"2025100702185661000_108.13.998.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2004.10.040"},{"key":"2025100702185661000_108.13.998.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2003.09.033"},{"key":"2025100702185661000_108.13.998.28","first-page":"157","article-title":"The effect of ageing on the frontal QRS-T angle on the 12-lead ECG","volume":"26","author":"Chaudhry","year":"2019","journal-title":"Br J Cardiol"},{"key":"2025100702185661000_108.13.998.29","first-page":"14","article-title":"Risk estimation of T wave alternans and ventricular late potentials in patients with cardiomyopathy","volume":"14","author":"Ashraf","year":"2018","journal-title":"Pak J Physiol"},{"key":"2025100702185661000_108.13.998.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00297-5"},{"key":"2025100702185661000_108.13.998.31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.joa.2016.02.009","article-title":"Cardiac dynamics: alternans and arrhythmogenesis","volume":"32","author":"Tse","year":"2016","journal-title":"J Arrhythm"},{"key":"2025100702185661000_108.13.998.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004968","article-title":"Electrophysiology of heart failure using a rabbit model: from the failing myocyte to ventricular fibrillation","volume":"12","author":"Ponnaluri","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2025100702185661000_108.13.998.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.010"},{"key":"2025100702185661000_108.13.998.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.018"},{"key":"2025100702185661000_108.13.998.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.748962"},{"key":"2025100702185661000_108.13.998.36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ehf2.12367","article-title":"Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation","volume":"6","author":"Zabel","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2025100702185661000_108.13.998.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2009.09.065"},{"key":"2025100702185661000_108.13.998.38","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90618-7"},{"key":"2025100702185661000_108.13.998.39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcmg.2020.07.016","article-title":"Inferior fragmented QRS as a new predictor of ventricular arrhythmias in patients with nonischemic cardiomyopathy","volume":"14","author":"Cho","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025100702185661000_108.13.998.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038804"},{"key":"2025100702185661000_108.13.998.41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2001.00772.x"},{"key":"2025100702185661000_108.13.998.42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1253\/circj.CJ-16-0683","article-title":"Utility of high-resolution magnetocardiography to predict later cardiac events in nonischemic cardiomyopathy patients with normal QRS duration","volume":"81","author":"Kawakami","year":"2016","journal-title":"Circ J"},{"key":"2025100702185661000_108.13.998.43","doi-asserted-by":"crossref","first-page":"f162","DOI":"10.1093\/europace\/euy080","article-title":"LifeMap: towards the development of a new technology in sudden cardiac death risk stratification for clinical use","volume":"20","author":"Ng","year":"2018","journal-title":"Europace"},{"key":"2025100702185661000_108.13.998.44","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305672"},{"key":"2025100702185661000_108.13.998.45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/pace.14143","article-title":"Application of two novel electrical restitution-based ECG markers of ventricular arrhythmia to patients with nonischemic cardiomyopathy","volume":"44","author":"Nicolson","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025100702185661000_108.13.998.46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2025100702185661000_108.13.998.47","article-title":"A novel gene signature to predict survival time and incident ventricular arrhythmias in patients with dilated cardiomyopathy","volume":"2020","author":"Ge","year":"2020","journal-title":"Dis Markers"},{"key":"2025100702185661000_108.13.998.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2020.04.025"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2021-319971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:19:08Z","timestamp":1759828748000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2021-319971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":48,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,6,10]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/heartjnl-2021-319971"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2021-319971","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}